Replies to post #188082 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

None of the trials have stated measures or endpoints that include EEG/ERP. I guess it is possible that other measures not mentioned in the protocol could be recorded with consent.

[nidan7500]

So all of the trials currently underway could be mining data to support ERP diagnostics...

Yes, that is possible. This technology is a perfect fit for Precision Medicine since it lends itself to measurements to the 6th decimal point and beyond for parameters which then can be translated to Biomarker db. Dose controls for example may be custom tuned as patients age/recover.

Cognision has been at this for a while, they have to be just ready to bust open. This is exactly the kind of technology that flies in the face of the FDA's statement on..para."we really do not know exactly where AD begins...stage 1 or 2 or likely 3." They said that after 30 years of trials, mind-blowing. No wonder we CNS treatment never got anywhere. A lot of very smart, capable people in FDA not well lead. It is fundamental, if it cannot be measured it cannot be controlled. FDA settled for subjective/error prone data on which treatment disposition decisions were made.

IMO, the good news is, we basically have a blank piece of paper. Many well done academic papers on this topic. My guess is that once the door gets opened there will be a continuous flow of new knowledge. That is what Precision Medicine will drive, IMO.